KR20250002095A - 계면활성제와 병용하기 위한 펩타이드 화합물을 포함하는 조성물 - Google Patents

계면활성제와 병용하기 위한 펩타이드 화합물을 포함하는 조성물 Download PDF

Info

Publication number
KR20250002095A
KR20250002095A KR1020247018318A KR20247018318A KR20250002095A KR 20250002095 A KR20250002095 A KR 20250002095A KR 1020247018318 A KR1020247018318 A KR 1020247018318A KR 20247018318 A KR20247018318 A KR 20247018318A KR 20250002095 A KR20250002095 A KR 20250002095A
Authority
KR
South Korea
Prior art keywords
less
peptide compound
surfactant
composition
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247018318A
Other languages
English (en)
Korean (ko)
Inventor
신이치 나카에
류스케 다카노
헝민 탕
유지 사쿠라이
Original Assignee
추가이 세이야쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2022/038128 external-priority patent/WO2023063376A1/ja
Application filed by 추가이 세이야쿠 가부시키가이샤 filed Critical 추가이 세이야쿠 가부시키가이샤
Publication of KR20250002095A publication Critical patent/KR20250002095A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
KR1020247018318A 2022-05-02 2023-04-19 계면활성제와 병용하기 위한 펩타이드 화합물을 포함하는 조성물 Pending KR20250002095A (ko)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
JP2022075833 2022-05-02
JPJP-P-2022-075833 2022-05-02
EP22192611 2022-08-29
EP22192611.6 2022-08-29
JPPCT/JP2022/038128 2022-10-12
PCT/JP2022/038128 WO2023063376A1 (ja) 2021-10-13 2022-10-12 ペプチド化合物及び界面活性剤を含む組成物
TW111138589 2022-10-12
TW111138589A TW202330014A (zh) 2021-10-13 2022-10-12 含有胜肽化合物及界面活性劑之組成物
EP22200995.3 2022-10-12
EP22200995.3A EP4166133B1 (en) 2021-10-13 2022-10-12 Composition containing peptide compound and surfactant
PCT/JP2023/015658 WO2023214509A1 (ja) 2022-05-02 2023-04-19 界面活性剤と併用するためのペプチド化合物を含む組成物

Publications (1)

Publication Number Publication Date
KR20250002095A true KR20250002095A (ko) 2025-01-07

Family

ID=88646467

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247018318A Pending KR20250002095A (ko) 2022-05-02 2023-04-19 계면활성제와 병용하기 위한 펩타이드 화합물을 포함하는 조성물

Country Status (7)

Country Link
US (1) US20250186542A1 (https=)
EP (1) EP4406546A4 (https=)
JP (1) JPWO2023214509A1 (https=)
KR (1) KR20250002095A (https=)
CN (1) CN118354782A (https=)
TW (1) TW202406566A (https=)
WO (1) WO2023214509A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI787670B (zh) 2011-12-28 2022-12-21 日商中外製藥股份有限公司 具有環狀部之胜肽化合物及其醫藥組成物
WO2024219446A1 (ja) * 2023-04-19 2024-10-24 中外製薬株式会社 環状ペプチド化合物及び界面活性剤を含む組成物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009518437A (ja) 2005-12-09 2009-05-07 ユニジーン・ラボラトリーズ・インコーポレーテッド 速効性経口ペプチド医薬品
WO2013100132A1 (ja) 2011-12-28 2013-07-04 中外製薬株式会社 ペプチド化合物の環化方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH679277A5 (https=) * 1989-02-09 1992-01-31 Sandoz Ag
US5912014A (en) * 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
NZ328751A (en) * 1997-09-16 1999-01-28 Bernard Charles Sherman Solid medicament containing an anionic surfactant and cyclosporin
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration
TW200409644A (en) * 2002-12-04 2004-06-16 Bio Max Inc Improved carrier system for cyclosporin pharmaceutical compositions
US9234023B2 (en) * 2010-06-24 2016-01-12 Biousian Biosystems, Inc. Glucagon-like peptide-1 glycopeptides
AU2012271691A1 (en) * 2011-06-14 2014-01-16 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
CN104853749A (zh) * 2012-09-17 2015-08-19 塔瑞克斯制药有限公司 血管紧张素的口服制剂
WO2016004067A1 (en) * 2014-06-30 2016-01-07 Stealth Biotherapeutics Corp Aromatic-cationic peptide formulations, compositions and methods of use
JP7232758B2 (ja) 2017-06-09 2023-03-06 中外製薬株式会社 膜透過性の高い環状ペプチド化合物、及びこれを含むライブラリ
WO2018225851A1 (ja) * 2017-06-09 2018-12-13 中外製薬株式会社 Ｎ－置換アミノ酸を含むペプチドの合成方法
PE20221323A1 (es) * 2019-11-07 2022-09-09 Chugai Pharmaceutical Co Ltd Compuesto de peptidos ciclicos que tiene accion inhibidora de kras

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009518437A (ja) 2005-12-09 2009-05-07 ユニジーン・ラボラトリーズ・インコーポレーテッド 速効性経口ペプチド医薬品
WO2013100132A1 (ja) 2011-12-28 2013-07-04 中外製薬株式会社 ペプチド化合物の環化方法

Also Published As

Publication number Publication date
JPWO2023214509A1 (https=) 2023-11-09
CN118354782A (zh) 2024-07-16
WO2023214509A1 (ja) 2023-11-09
TW202406566A (zh) 2024-02-16
US20250186542A1 (en) 2025-06-12
EP4406546A4 (en) 2025-10-08
EP4406546A1 (en) 2024-07-31

Similar Documents

Publication Publication Date Title
KR20250002095A (ko) 계면활성제와 병용하기 위한 펩타이드 화합물을 포함하는 조성물
WO2024219446A1 (ja) 環状ペプチド化合物及び界面活性剤を含む組成物
CN107096012A (zh) 肽的组合物及其制备方法
CN102464701B (zh) 一类新型化合物、其制备方法及用途
KR20240070705A (ko) 펩타이드 화합물 및 계면활성제를 포함하는 조성물
TW202308679A (zh) 包含環狀胜肽化合物的製劑及其製造方法
KR20190039034A (ko) 특화된 사전 해소 매개체의 염에 관한 조성물 및 방법
WO2015162195A1 (en) Fatty acid acylated amino acids for oral peptide delivery
TW202402319A (zh) 含有包含聚氧乙烯構造的油性成分之化合物製劑
HK40111891A (zh) 用於与表面活性剂联用的包含肽化合物的组合物
HK40111890A (zh) 包含肽化合物和表面活性剂的组合物
AU2017308830A1 (en) Pharmaceutical formulations and their use
EP4582092A1 (en) Composition containing peptide, surfactant, and polymer
US12582694B2 (en) Compounds and methods for inhibiting protozoan parasites
CN118176012A (zh) 包含肽化合物和表面活性剂的组合物
JP2024528195A (ja) ブラジキニンｂ２受容体拮抗薬を経口投与するための脂質ベースの組成物
JP4767256B2 (ja) 安定化したロイコトリエンｂ４（ｌｔｂ４）剤の医薬製剤
HK40126562A (zh) 含有环肽化合物和表面活性剂的组合物
HK40111865A (zh) 含有包含聚氧乙烯结构的油性成分的化合物制剂
JP2010280705A (ja) プロトン駆動型トランスポーター介在型消化管吸収改善剤及びその製法

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000